Open access peer-reviewed chapter

Sudden Death Circadian Rhythm in Chagasic Patients Compared to Non-Chagasic Patients

Written By

Juan Marques, Iván Mendoza and Claudia Suarez

Submitted: November 1st, 2017 Reviewed: March 5th, 2018 Published: July 4th, 2018

DOI: 10.5772/intechopen.76212

Chapter metrics overview

960 Chapter Downloads

View Full Metrics


Chagas disease (Ch) affects 8–10 million people in Latin America. Sudden death is the major cause of death in patients with Ch. Objective: To compare the circadian rhythm of sudden death in Ch vs. non-Ch patients. Methods: Retrospective analysis of all the cases of sudden death (SD) is recorded in our department, including autopsied patients from 1963 until 2011. Pattern of death of 266 patients (116 Ch and 146 non-Ch), 56.7% men, average age 54, 6 years old, divided into four groups: Group A: Ch with SD (n = 38), Group B: non-Ch with SD (n = 58), Group C: Ch with non-SD (n = 81), and Group D: non-Ch with non-SD (n = 89). Results: 44.7% (17/38) of sudden deaths in Group A (Ch) occurred between 6 am and 5:59 pm, while for Group B (not Ch) 70.7% (41/58) died in that time (p < 0.005). Between 6 pm and 5:59 am occurred 55.3% (21/38) of the SD in Group A (Ch) compared with 29.3% (17/58) in Group B (p < 0.005). Conclusions: Circadian rhythm of SD in patient with Ch differs from those patients with non-CH. In CH patients, SD occurs predominantly during the night compared with non-Ch SD that occurs predominantly during the morning.


  • sudden death
  • cardiomyopathy
  • circadian rhythm
  • Chagas disease

1. Introduction

The Chagas disease is a malady caused by the Trypanosoma cruzi protozoan, and it represents an endemic disease in Latin America, affecting 8–10 million of patients, most of them being poor [1, 2]. It is estimated that 400,000 infected persons live in nonendemic countries, mainly in the United States and Europe [3, 4]. A recent meta-analysis of European studies that, in aggregate, screened 10,000 Latin American immigrants found a positive serological test prevalence of 4.2% [5]. Based on published seroprevalence in Latin American immigrant populations (1.31%), it was estimated that approximately 300,000 individuals with T. cruzi infection live in the United States, with 30,000–45,000 cardiomyopathy cases and 63–315 congenital infections annually [6].

The sudden death circadian variation has been demonstrated in two large-scale studies, the Framingham Heart Study [7] and the Massachusetts Death Certificate Study [8]. Both studies show a peak of sudden deaths between 7 and 11 am with a lower incidence during sleep, which is similar to the rate of ischemic and arrhythmic events [9, 10]. The sudden death is the main cause of death in those patients with the Chagas disease, being responsible of the 55–65% of their deaths [11]. Lopes et al. [12] demonstrated that there is a sudden death circadian rhythm in Chagasic patients. In this study, 50 cases of Chagasic sudden death, along with 473 cases of nonsudden natural death, were compared in several centers. To the best of our knowledge, this is the first report that compares the rhythm of the sudden and nonsudden death of Chagasic patients vs. non-Chagasic patients with cases within a same center.


2. Material and methods

A retrospective study of a consecutive series of sudden death cases, registered within our department between 1963 and 2011, including the ECG records, Holter records from sudden death victims, autopsies, and the Death report by the relatives. The Chagas disease diagnosis was performed through serological studies, or a necroscopic study was performed in the cases of autopsies.

The date and time of death were collected from necropsy protocols and/or emergency clinical histories, as well as data obtained from relatives and witnesses.

Sudden cardiac death (SCD) is generally defined as a sudden and unexpected pulseless event, but noncardiac conditions need to be excluded before the occurrence of a primary cardiac event can be confirmed [13]. A case of established SCD is an unexpected death without obvious extracardiac cause, occurring with a rapid witnessed collapse, or if unwitnessed, occurring within 1 h after the onset of symptoms [13]. A probable SCD is an unexpected death without obvious extracardiac cause that occurred within the previous 24 h [13]. In any situation, the death should not occur in the setting of a prior terminal condition, such as a malignancy that is not in remission or end-stage chronic obstructive lung disease [13]. In our study, we included both established and probable SCD.

A total of 266 cases were analyzed; 56.7% of the subjects were male with an average age of 54.6 years, which were divided into four groups: Group A: Chagasic patients with sudden death, n = 38; Group B: non-Chagasic patients with sudden death, n = 58; Group C: Chagasic patients with non-sudden death, n = 89; and Group D: non-Chagasic patients with non-sudden death, n = 81.

The results were assessed using exploratory data analysis (EDA) and comparison of ratio differential. As the statistic validation rule, a p-value <0.05 was considered as statistically significant.


3. Results

A total number of cases per hour of sudden death in patients with and without Ch are shown in Figure 1. Figure 2 shows the number of cases per hour of nonsudden death in patients with and without Ch. After analyzing the data divided into 12-h periods (day and night), significant differences were observed. Figure 3 shows the percentages of cases from the SD groups occurring during night and day. Forty four point seven per cent (44.7%) (17/38) of the sudden deaths in Group A (Ch) occurred between 6 am and 5:59 pm, while for Group B (non-Ch), 70.7% (41/58) of the patients died within that time (p < 0.005). Between 6 pm and 5:59 am, 55.3% (21/38) of the deaths of Group A (Ch) occurred in that time compared to 29.3% (17/58) from Group B (p < 0.005). Figure 4 shows the data of nonsudden death cases. 49.4% (40/81) of Group C (Ch non-SD) died between 6 am and 5:59 pm compared to 59.6% (53/89) of Group D (non-Ch, non-SD), (p not significant), while between 6 pm and 5:59 am, 50.6% of Group C (Ch, non-SD) cases died compared to 40.4% (36/53) of Group D (non-Ch, non-SD) (p was not significant).

Figure 1.

Sudden death of circadian rhythm.

Figure 2.

Circadian rhythm of nonsudden death.

Figure 3.

Comparison of 12-h periods of sudden death of Chagasic and non-Chagasic patients.

Figure 4.

Comparison of 12-h periods of nonsudden death in Chagasic vs. non-Chagasic patients.

In order to perform a more detailed analysis, the percentages of cases were grouped within 3-h periods: (6–8, 9–11, 12–14, 15–17, 18–20, 21–23, 24–2, 3–5). Figure 5 shows the circadian rhythm of sudden death in Chagasic patients (Group A) compared to the non-Chagasic patients (Group B). Within these periods, a higher death percentage in the Chagasic group is observed within the 21–23 h interval (34 vs. 3%, p = 0.0001), while the non-Chagasic arm presented a higher percentage of cases within the 9–11 h range (43 vs. 3%, p < 0.0001), of 24 to 21 2 h (10 vs. 0% p < 0.005), and from 3 to 5 h (7 vs. 0%, p < 0.005). The difference of the other analyzed periods was not significant. When comparing the number of cases of non-sudden deaths in Chagasic patients vs. non-Chagasic patients, a significant difference in any of the analyzed ranges was not observed.

Figure 5.

Sudden death circadian rhythm in Chagasic patients compared to non-Chagasic patients.


4. Discussion

The sudden death is the primary cause of death in patients suffering from Chagas disease, representing around 60% of the total cases [11], hence the importance of its study. Our study clearly evidenced that in Chagasic patients, the higher percentage of cases of sudden death occurred during the nighttime (Figures 1, 3, and 5). When we analyzed the non-sudden death results, no difference between the Chagasic and non-Chagasic arms was observed (Figures 2 and 4). Our results agree with those of Lopes et al. [8], who demonstrated a sudden death predominance in Chagasic patients during the nighttime. On the other hand, our study also agrees with previous studies in the non-Chagasic population in the United States, which were a predominance of sudden death cases occurred in the morning [7, 8]. The importance of our study lies in two milestones:

(1) This study represents the largest series reported to date comparing the sudden death circadian rhythm in Chagasic and non-Chagasic patients. (2) The fact that this study represents a series where all included patients belonged to the same center within a Latin American country, allowing a better group comparison.

The potential mechanisms for the sudden death circadian variation in the general population are not entirely clear, especially since due to the interaction among them, it is difficult to independently determine the importance of each factor. The proposed mechanisms include:

  1. Autonomic nervous system alterations.

    It is being proposed that both the sympathetic nervous system and the parasympathetic system may stimulate the circadian variation. Using the frequency domain, it has been demonstrated an unfavorable variability profile of the heart rate in the morning time. [14, 15, 16, 17] This may be caused by both the sympathetic tone endogen variations and the increasing level of physical activity [15, 16, 17]. The use of beta-blockers reduces or removes the morning peak of ischemic and arrhythmic events [18, 19, 20, 21, 22], which supports the hypothesis of increasing adrenergic tone, since this same effect is not achieved via antiarrhythmic non-beta blockers medication [23]. Generally, the HRV indexes significantly decrease during the daytime and increase during the night [24, 25, 26, 27, 28, 29, 30].On the other hand, the variations of autonomic tone and parasympathetic-sympathetic balance have been proposed as the cause, which have been analyzed through heart rate variations (HRV) [31, 32, 33, 34, 35].

  2. Morning variations of the electrophysical properties.

    In both invasive electrophysiological studies [28] and non-invasive studies using permanent pacemaker telemetry [15, 31], circadian variation of the ventricular refractory has been demonstrated, being the last lower during the morning time and higher during sleep.

    This variation does not seem to be related to the potassium or circulating catecholamine levels [31]; on the other hand, it would be aligned with the variations of the maximum QT interval [33].

  3. Circadian variation of ischemic episodes.

    A peak in the morning and in the afternoon of ischemia-related conditions, such as the myocardial infraction [22, 34, 35], anginal crisis [36, 37, 38], and strokes, [39, 40] has been reported. These episodes have been related to morning variations of the endothelial function [41] and of thrombogenesis biochemical markers [42, 43, 44, 45, 46]. Durgan et al. [47] demonstrated that there is a relation between the date time and the tolerance to reperfusion-ischemia in cardiomyocytes of isolated mice, being the lowest tolerance during the morning time.

The factors that may bias for the circadian rhythm to be different in patients with Chagas disease are not clear; however, several hypotheses have been posed:

  1. The autonomic balance of Chagasic patients, which has been evidenced by several authors [48, 49, 50]. Cardiac autonomic dysfunction, characterized mainly by parasympathetic depression, is present in human and experimental Chagas disease, even in patients with minor ECG alterations [51].

  2. The endothelial dysfunction [52].

  3. The presence of antibodies against the adrenergic receivers may reduce the morning adrenergic activity, hence, suppressing the morning peak [53].

Abello et al. [54], when analyzing 22 Chagasic patients with third-generation implantable defibrillators, demonstrated a ventricular tachycardia circadian rhythm pattern, characterized by a frequency peak between noon and 18:00 h with a nadir between 24:00 and 6:00 h, which would be in line with our results.


5. Conclusion

The sudden death circadian rhythm in Chagasic patients significantly differs from that of the non-Chagasic patients, showing a greater prevalence during the nighttime. Further studies are needed in order to analyze both the prognostic implications and the therapeutic ones.


6. Limitations

Regarding the certainty of the time of death, the study limitation is common to that of all sudden death studies, since the time of death, which is mostly reported by a witness, decreasing the accuracy of the data. In most of the times, we ignored the personal history of the patients (previous pathology, concomitant treatment, etc.) because the death occurred suddenly. Also, we do not have previous data from other complementary explorations such as echocardiogram, stress test, and so on in much of the cases.


Conflict of interest

Juan Marques, Medical Director of MSD Mexico.





  1. 1. Rassi Jr A, Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010;375:1388-1402
  2. 2. Organización Panamericana de la Salud. Estimación cuantitativa de la enfermedad de Chagas en las Americas. Montevideo, Uruguay: Organización Panamericana de la Salud; 2006. (Report No. OPS/HDM/CD/425-06)
  3. 3. Bern C. Chagas’ disease. The New England Journal of Medicine. 2015;373:456-466
  4. 4. Pinazo MJ, Miranda B, Rodríguez-Villar C, et al. Recommendations for management of Chagas disease in organs and hematopoietic tissue transplantation programs in nonendemic areas. Transplantation Reviews (Orlando, Fla.). 2011;25:91-101
  5. 5. Requena-Méndez A, Aldasoro E, de Lazzari E, et al. Prevalence of Chagas disease in Latin American migrants living in Europe: A systematic review and meta-analysis. PLoS Neglected Tropical Diseases 2015;9:e0003540
  6. 6. Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the United States. Clinical Infectious Diseases. 2009;49:e52-e54
  7. 7. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 1989;79:733-743
  8. 8. Willich SN, Levy D, Rocco MB, Tofler GH, Stone PH, Muller JE. Circadian variation in the incidence of sudden cardiac death in the Framingham heart study population. The American Journal of Cardiology. 1987;60:801-806
  9. 9. Guo YF, Stein PK. Circadian rhythm in the cardiovascular system: Chronocardiology. American Heart Journal. 2003;145(5):779-786
  10. 10. Willich SN, Goldberg RJ, Maclure M, Perriello L, Muller JE. Increased onset of sudden cardiac death in the first three hours after awakening. The American Journal of Cardiology. 1992;70(1):65-68
  11. 11. Rassi Jr A, Rassi SG, Rassi A. Sudden death in Chagas’s disease. Arquivos Brasileiros de Cardiologia. 2001;76(1):75-79
  12. 12. Lopes ER, da Cunha LF, dos Santos TA, Resende AV, Jorge BH, Salomão LA, Rodrigues RT. Variações circadianas diárias e semanais na morte súbita da Doença de Chagas. Arquivos Brasileiros de Cardiologia 1993;61:345-348
  13. 13. Fishman GI, Chugh SS, DiMarco JP, Albert CM, Anderson ME, Bonow RO, Buxton AE, Chen P-S, Estes M, Jouven X, Kwong R, Lathrop DA, Mascette AM, Nerbonne JM, O'Rourke B, Page RL, Roden DM, Rosenbaum DS, Sotoodehnia N, Trayanova NA, Zheng Z-J. Sudden cardiac death prediction and prevention. Circulation. 2010;122:2335-2348
  14. 14. Hohnloser SH, Klingenheben T. Insights into the pathogenesis of sudden cardiac death from analysis of circadian fluctuations of potential triggering factors. Pacing and Clinical Electrophysiology. 1994;17:428-433
  15. 15. Huikuri HV, Yli-Mayry S, Linnaluoto MK, Ikaheimo MJ. Diurnal fluctuations in human ventricular and atrial refractoriness. Pacing and Clinical Electrophysiology. 1995;18:1362-1368
  16. 16. Klingenheben T, Rapp U, Hohnloser SH. Circadian variation of heart rate variability in postinfarction patients with and without life- threatening ventricular tachyarrhythmias. Journal of Cardiovascular Electrophysiology. 1995;6(5):357-364
  17. 17. Nakagawa M, Saikawa T, Ito M. Progressive reduction of heart rate variability with eventual sudden death in two patients. British Heart Journal. 1994;71:87-88
  18. 18. Aronow WS, Ahn C, Mercando AD, Epstein S. Effect of propranolol on circadian variation of myocardial ischemia in elderly patients with heart disease and complex ventricular arrhythmias. The American Journal of Cardiology. 1995;75:837-839
  19. 19. Behrens S, Ehlers C, Bruggemann T, Ziss W, Dissmann R, Galecka M, et al. Modification of the circadian pattern of ventricular tachyarrhythmias by beta blocker therapy. Clinical Cardiology. 1997;20:253-257
  20. 20. Peters RW, Muller JE, Goldstein S, Byington R, Friedman LM. Propranolol and the morning increase in the frequency of sudden cardiac death (BHAT study). The American Journal of Cardiology. 1989;63(20):1518
  21. 21. Kupari M, Koskinen P, Leinonen H. Double-peaking circadian variation in the occurrence of sustained supraventricular tachyarrhythmias. American Heart Journal. 1990;120:1364-1369
  22. 22. Muller JE, Stone PH, Turi ZG, Rutherford JD, Czeisler CA, Parker C, et al, and the MILIS Study Group. Circadian variation in the frequency of onset of acute myocardial infarction. The New England Journal of Medicine 1985;313:1315-1322
  23. 23. Peters RW, Mitchell LB, Brooks MM, Echt DS, Barker AH, Capone R, et al. for the CAST Investigators. Circadian pattern of arrhythmic death in patients receiving encainide, flecainide or moricizine in the cardiac arrhythmia suppression trial (CAST). Journal of the American College of Cardiology 1994;23:283-289
  24. 24. Furlan R, Guzzetti S, Crivellaro W, Dassi S, Tinelli M, Baselli G, Cerutti S, Lombardi F, Pagani M, Malliani A. Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. Circulation. 1990;81:537-547
  25. 25. Yamasaki Y, Kodama M, Matsuhisa M, Kishimoto M, Ozaki H, Tani A, Ueda N, Ishida Y, Kamada T. Diurnal heart rate variability in healthy subjects: Effects of aging and sex difference. The American Journal of Physiology. 1996;271:H303-H310
  26. 26. De Scalzi M, De Leonardis V, Calzolari F, Barchielli M, Cinelli P, Chiodi L, Fabiano FS, Vergassola R. Heart rate and premature beats: A chronobiologic study. Giornale Italiano di Cardiologia. 1984;14:465-470
  27. 27. Lombardi F, Sandrone G, Mortara A, La Rovere MT, Colombo E, Guzzetti S, Malliani A. Circadian variation of spectral indices of heart rate variability after myocardial infarction. American Heart Journal. 1992;123:1521-1529
  28. 28. Korpelainen JT, Sotaniemi KA, Huikuri HV, Myllylä VV. Circadian rhythm of heart rate variability is reversibly abolished in ischemic stroke. Stroke. 1997;28:2150-2154
  29. 29. Haseroth K, Löffler P, Janson CP, Kropff S, Schmidt BM, Feuring M, Christ M, Wehling M. Acute effects of a single oral dose of carvedilol on cardiac sympathovagal balance in man. International Journal of Clinical Pharmacology and Therapeutics. 2001;39:315-321
  30. 30. Massin MM, Maeyns K, Withofs N, Ravet F, Gérard P. Circadian rhythm of heart rate and heart rate variability. Archives of Disease in Childhood. 2000;83:179-182
  31. 31. Kong Jr TQ, Goldberger JJ, Parker M, Wang T, Kadish AH. Circadian variation in human ventricular refractoriness. Circulation. 1995;92:1507-1516
  32. 32. Cinca J, Moya A, Figueras J, Roma F, Rius J. Circadian variations in the electrical properties of the human heart assessed by sequential bedside electrophysiologic testing. American Heart Journal. 1986;112:315-321
  33. 33. Molnar J, Zhang F, Weiss J, Ehlert FA, Rosenthal JE. Diurnal pattern of QTc interval. How long is prolonged? Possible relation to circadian triggers of cardiovascular events. Journal of the American College of Cardiology. 1996;27:76-83
  34. 34. Cannon CP, McCabe CH, Stone PH, Schactman M, Thompson B, Theroux P, Gibson RS, Feldman T, Kleiman NS, Tofler GH, Muller JE, Chaitman BR, Braunwald E. Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III registry and TIMI IIIB). The American Journal of Cardiology. 1997;79:253-258
  35. 35. Behar S, Halabi M, Reicher-Reiss H, Zion M, Kaplinsky E, Mandelzweig L, Goldbourt U. Circadian variation and possible external triggers of onset of myocardial infarction. SPRINT Study Group. American Journal of Medicine. 1993;94:395-400
  36. 36. Hausmann D, Lichtlen PR, Nikutta P, Wenzlaff P, Daniel WG. Circadian variation of myocardial ischemia in patients with stable coronary artery disease. Chronobiology International. 1991;8:385-398
  37. 37. Behar S, Reicher-Reiss H, Goldbourt U, Kaplinsky E. Circadian variation in pain onset in unstable angina pectoris. The American Journal of Cardiology. 1991;67:91-93
  38. 38. Hausmann D, Nikutta P, Trappe HJ, Daniel WG, Wenzlaff P, Lichtlen PR.Circadian distribution of the characteristics of ischemic episodes in patients with stable coronary artery disease. The American Journal of Cardiology 1990;66:668-672
  39. 39. Argentino C, Toni D, Rasura M, Violi F, Sacchetti ML, Allegretta A, Balsano F, Fieschi C. Circadian variation in the frequency of ischemic stroke. Stroke. 1990;21:387-389
  40. 40. Wroe SJ, Sandercock P, Bamford J, Dennis M, Slattery J, Warlow C. Diurnal variation in incidence of stroke: Oxfordshire community stroke project. British Medical Journal. 1992;304:155-157
  41. 41. El-Tamimi H, Mansour M, Pepine CJ, Wargovich TJ, Chen H. Circadian variation in coronary tone in patients with stable angina. Protective role of the endothelium. Circulation 1995;92:3201-3205
  42. 42. Kurnik PB. Circadian variation in the efficacy of tissue-type plasminogen activator. Circulation. 1995;91:1341-1346
  43. 43. Bridges AB, McLaren M, Scott NA, Pringle TH, McNeill GP, Belch JJ. Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease. British Heart Journal 1993;69:121-124
  44. 44. Angleton P, Chandler WL, Schmer G. Diurnal variation of tissue- type plasminogen activator and its rapid inhibitor (PAI-1). Circulation. 1989;79:101-106
  45. 45. Sakata K, Hoshino T, Yoshida H, Ono N, Ohtani S, Yokoyama S, Mori N, Kaburagi T, Kurata C, Urano T, et al. Circadian fluctuations of tissue plasminogen activator antigen and plasminogen activator inhibitor-1 antigens in vasospastic angina. American Heart Journal. 1992;124:854-860
  46. 46. Ogawa H, Yasue H, Oshima S, Okumura K, Matsuyama K, Obata K. Circadian variation of plasma fibrinopeptide A level in patients with variant angina. Circulation. 1989;80:1617-1626
  47. 47. Durgan DJ, Pulinilkunnil T, Villegas-Montoya C, Garvey ME, Frangogiannis NG, Michael LH, Chow CW, Dyck JR, Young ME. Short communication: Ischemia/reperfusion tolerance is time-of-day-dependent: Mediation by the cardiomyocyte circadian clock. Circulation Research. 2010;106(3):546-550
  48. 48. Junqueira LF Jr. Sobre o possível papel da disfunção autonômica cardíaca na morte súbita associada à doença de Chagas. Arquivos Brasileiros de Cardiologia. 1991;56:429-434
  49. 49. Carrasco Guerra HA, Jugo D, Medina R, Castilo C, Miranda P. Electrocardiograma de alta resolución y variabilidad de la frecuencia cardiaca en pacientes chagásicos crónicos. Archivos del Instituto de Cardiología de México. 1997;67:277-285
  50. 50. Ribeiro AL, Moraes RS, Ribeiro JP, Ferlin EL, Torres RM, Oliveira E, Rocha MO. Parasympathetic dysautonomia precedes left ventricular systolic dysfunction in Chagas disease. American Heart Journal. 2001;141:260-265
  51. 51. Vasconcelos DF, Junqueira-Júnior LF. Funções autonômica cardíaca e mecânica ventricular na Cardiopatia Chagásica Crônica assintomática. Arquivos Brasileiros de Cardiologia. 2012;98:111-119
  52. 52. Torres FW, Acquatella H, Condado JA, Dinsmore R, Palacios IF. Coronary vascular reactivity is abnormal in patients with Chagas' heart disease. American Heart Journal. 1995;129(5):995-1001
  53. 53. Chiale PA, Ferrari I, Mahler E, Vallazza MA, Elizari MV, Rosenbaum MB, et al. Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation. 2001;103:1765-1771
  54. 54. Abello M, González-Zuelgaray J, Daglio ME, Lopez C, Garraza S, Szyszko A. Circadian pattern of ventricular tachycardia episodes in patients with Chagas heart disease. Arquivos Brasileiros de Cardiologia. 2007;88(2):240-242

Written By

Juan Marques, Iván Mendoza and Claudia Suarez

Submitted: November 1st, 2017 Reviewed: March 5th, 2018 Published: July 4th, 2018